Evidence map›Paper›PMID 41847683›Full record

ArticleFrontiers in neurology

EEFSA-SECM: an enhanced ensemble feature selection and stacking ensemble classifier to detect Parkinson's disease.

Vridhi Rajput, N Maheswari

Abstract read
In one paragraph

Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Vridhi RajputSchool of Computer Science and Engineering, Vellore Institute of Technology, Chennai, India.
N MaheswariSchool of Computer Science and Engineering, Vellore Institute of Technology, Chennai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Parkinson's disease (PD) is a progressive neurological disorder whose early symptoms often remain undetected, making timely diagnosis challenging. Machine learning offers strong algorithms to detect subtle speech-based biomarkers that are impossible to detect by standard methods. Methods: In this article, we proposed an Enhanced Ensemble Feature Selection Algorithm (EEFSA) which combines filter, wrapper, and embedded approaches to extract the best informative features, eliminate redundancy, and improve classification performance. The proposed work has tested on two benchmark audio based datasets, such as Dataset-1 (46 features, 80 samples), where EEFSA reduced the features to 20 features, and Dataset-2 (754 features, 252 samples), where EEFSA reduced the features to 40 features. Nine machine learning classifiers were tried out and the best of them were combined into a stacking ensemble with logistic regression as the meta-classifier. Results: Experiments show that EEFSA-driven dimensionality reduction not only enhanced accuracy of classification but also reduced training time considerably and minimized over fitting. The Stacking Ensemble Classifier Model (SECM) deployed on the basis of the proposed method achieved accuracy of 86.67% and 89.95% on Dataset-1 and Dataset-2, respectively, and outperformed individual classifiers in all experiments. Conclusion: Overall, this work provides EEFSA-driven stacking as a new and efficient method of feature selection and ensemble learning combination for Parkinson's disease classification. The proposed EEFSA-SECM framework achieves effective classification accuracy, competitive training/testing times, and improved AUC scores on two benchmark datasets, establishing it as an effective and efficient approach for Parkinson's disease diagnosis.

Indexed as

classifierensemblefeature selectionParkinson’s diseasespeech

Identifiers

PMID41847683
PMCPMC12989349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.